HomeJUBLPHARMA • NSE
add
Jubilant Pharmova Ltd
Previous close
₹902.70
Day range
₹882.30 - ₹917.75
Year range
₹538.05 - ₹1,309.90
Market cap
142.68B INR
Avg Volume
337.25K
P/E ratio
22.78
Dividend yield
0.56%
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
(INR) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 18.22B | 8.62% |
Operating expense | 10.51B | 3.28% |
Net income | 1.01B | 51.05% |
Net profit margin | 5.54 | 39.20% |
Earnings per share | — | — |
EBITDA | 2.64B | 37.87% |
Effective tax rate | 22.84% | — |
Balance Sheet
Total assets
Total liabilities
(INR) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 10.77B | 10.60% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 59.27B | — |
Shares outstanding | 158.40M | — |
Price to book | 2.41 | — |
Return on assets | — | — |
Return on capital | 5.44% | — |
Cash Flow
Net change in cash
(INR) | Dec 2024info | Y/Y change |
---|---|---|
Net income | 1.01B | 51.05% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1978
Headquarters
Website
Employees
5,399